AvenCell Europe GmbH

AvenCell Europe GmbH

General
Jobs 0
Shortlists/Awards 1
Pricing strategy 0
Partners/Competitors 4
Last update: Dec 6, 2024 Last update: Dec 6, 2024
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:Germany
Organization type:Consulting organization
Funding agencies:Other, Horizon Europe
Other, Horizon Europe (2021 - 2027)
Sectors:Health, Science & Innovation
Health, Science & Innovation
Nr. of employees:11-50
Sanctions:Check now
Status:
Active

Attachments 0

About

AvenCell Therapeutics, Inc. was recently launched by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics and incorporated the clinical-stage biopharmaceutical company GEMoaB GmbH, now named AvenCell Europe GmbH. AvenCell’s mission is to overcome the limitations of current-generation CAR-T cell therapies with an improved therapeutic window and substantially expand the types of cancer, including solid tumors, treatable with adoptive cell therapy. 

Awards

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.
Similar Companies